COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration ― United States, May 11, 2023

COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022

(2023) Amelia G. Johnson et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022

(2022) Anastasia S. Lambrou et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021

(2022) Jefferson M. Jones et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022

(2022) Mark W. Tenforde et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022

(2022) Melisa M. Shah et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022

(2022) Diya Surie et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Advancements in the National Vital Statistics System to Meet the Real-Time Data Needs of a Pandemic

(2021) Farida B. Ahmad et al.   AMERICAN JOURNAL OF PUBLIC HEALTH